Study S000588

Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07676331
Acronym: CLARA
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 168
Start: 2026-08-01
Primary completion: 2028-03-01
Lead sponsor: Universitaire Ziekenhuizen KU Leuven
Conditions: Hormone-receptor-positive Breast Cancer; Early Breast Cancer
Interventions: DRUG:Tirzepatide; DRUG:Letrozole (Aromatase Inhibitors)
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: EUDRACT_NUMBER:2026-525820-76

Registered primary outcomes

Ki67 proliferation marker [From enrollment till time of surgery (4-5 weeks)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.